1. Type III Secretion System in Intestinal Pathogens and Metabolic Diseases.
- Author
-
Zhou L, Zhang Y, Wu S, Kuang Y, Jiang P, Zhu X, and Yin K
- Subjects
- Humans, Animals, Intestines microbiology, Metabolic Diseases microbiology, Metabolic Diseases metabolism, Type III Secretion Systems metabolism, Gastrointestinal Microbiome physiology
- Abstract
Modern lifestyle changes, especially the consumption of a diet high in salt, sugar, and fat, have contributed to the increasing incidence and prevalence of chronic metabolic diseases such as diabetes, obesity, and gout. Changing lifestyles continuously shape the gut microbiota which is closely related to the occurrence and development of metabolic diseases due to its specificity of composition and structural diversity. A large number of pathogenic bacteria such as Yersinia , Salmonella , Shigella , and pathogenic E. coli in the gut utilize the type III secretion system (T3SS) to help them resist host defenses and cause disease. Although the T3SS is critical for the virulence of many important human pathogens, its relationship with metabolic diseases remains unknown. This article reviews the structure and function of the T3SS, the disruption of intestinal barrier integrity by the T3SS, the changes in intestinal flora containing the T3SS in metabolic diseases, the possible mechanisms of the T3SS affecting metabolic diseases, and the application of the T3SS in the treatment of metabolic diseases. The aim is to provide insights into metabolic diseases targeting the T3SS, thereby serving as a valuable reference for future research on disease diagnosis, prevention, and treatment., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2024 Le Zhou et al.)
- Published
- 2024
- Full Text
- View/download PDF